• In recent months, Rocket Lab has secured its largest-ever US$816 million U.S. Space Development Agency contract, an additional U.S. Space Force award potentially approaching US$1 billion, and new missions with Canadian and Japanese space agencies, while preparing to showcase its progress at BofA’s 2026 Defense Outlook and Commercial Aerospace Forum.
• These expanding government partnerships highlight how Rocket Lab’s space systems and defense-focused technologies are becoming central to its business mix beyond launch services.
• We’ll now examine how Rocket Lab’s major U.S. defense contracts reshape the company’s investment narrative and future risk-reward profile.

Uncover the next big thing with financially sound penny stocks that balance risk and reward.

Rocket Lab Investment Narrative Recap

To own Rocket Lab today, you need to believe it can turn its expanding defense and space systems footprint into a sustainable, profitable business while funding heavy Neutron spending and managing contract lumpiness. The recent US$816 million SDA award and U.S. Space Force contract materially support the short term catalyst of scaling high value government programs, but they do not remove the biggest risk around ongoing cash burn, potential dilution and execution on Neutron and large satellite contracts.

Among the recent announcements, the SDA missile tracking satellite contract stands out as most relevant, because it reinforces how space systems and defense work are becoming more central to Rocket Lab’s story than Electron launch cadence. This shift matters for investors watching whether the company can smooth its revenue profile over time and reduce reliance on winning a small number of very large, timing sensitive programs, even as Neutron development continues to consume significant capital.

Yet beneath the contract wins, investors should still be aware that sustained high R&D spending on Neutron and dependence on a few large defense programs could...

Rocket Lab’s narrative projects $1.3 billion revenue and $113.4 million earnings by 2028. This requires 37.5% yearly revenue growth and a $344.7 million earnings increase from -$231.3 million today.

Uncover how Rocket Lab's forecasts yield a $68.75 fair value, a 21% downside to its current price.

Exploring Other Perspectives

Seventy five members of the Simply Wall St Community currently see Rocket Lab’s fair value anywhere between US$10.61 and US$97.83, with views spread across that full range. Against this wide dispersion, the company’s reliance on large, lumpy defense contracts as a key catalyst and risk shows why it can help to compare several different viewpoints before deciding how you see Rocket Lab’s potential performance.

Explore 75 other fair value estimates on Rocket Lab - why the stock might be worth less than half the current price!

Build Your Own Rocket Lab Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Rocket Lab research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Rocket Lab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rocket Lab's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• This technology could replace computers: discover 29 stocks that are working to make quantum computing a reality.
• We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.